COMMUNICATION
|
doi:10.20944/preprints202309.1496.v2
Subject:
Medicine And Pharmacology,
Clinical Medicine
Keywords:
pemafibrate; Non-alcoholic fatty liver disease (NAFLD); Alanine Aminotransferase; M2-BPGi; dyslipidemia; liver fibrosis
Online: 27 September 2023 (10:02:35 CEST)